首页> 外文期刊>Journal of Surgical Oncology >Clinical significance of the discrepancy between preoperative and postoperative diagnoses in gastric cancer patients.
【24h】

Clinical significance of the discrepancy between preoperative and postoperative diagnoses in gastric cancer patients.

机译:胃癌患者术前诊断与术后诊断差异的临床意义。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Discrepancies between pre- and postoperative diagnoses can lead to dilemma for operative management adequacy. PATIENTS AND METHODS: A total of 2,910 patients with gastric adenocarcinoma underwent curative surgery at the Samsung Medical Center between 2001 and 2003. Patients were divided into four groups: early gastric cancer (EGC)-EGC group that consisted of subjects who were diagnosed as having EGC pre- and postoperatively, advanced gastric cancer (AGC)-EGC group, EGC-AGC group, and AGC-AGC group. Clinicopathologic features and survival rates of groups were analyzed retrospectively. RESULTS: Of the 2,910 patients, 1,491 (51.2%) patients were included in the EGC-EGC group, 132 (4.5%) in the AGC-EGC group, 120 (4.1%) in the EGC-AGC group, and 1,167 (40.1%) in the AGC-AGC group. The EGC-AGC group showed higher proportions of the followings than the EGC-EGC group: upper-third and middle-third tumor localizations, a tumor size from 2 to 5 cm, undifferentiated adenocarcinoma, Lauren's diffuse type, endolymphatic invasion, vascular invasion, and perineural invasion. Five-year survival rates were dependent on the final pathologic stages, not on the preoperative stages. Multivariate analysis revealed that age and American Joint Committee of Cancer stage were independent prognostic factors of patient survival. CONCLUSION: A decision regarding minimally invasive treatment for EGC must be made having considered tumor location, size, and cellular differentiation, because of the possibility of an incorrect preoperative diagnosis.
机译:背景:术前和术后诊断之间的差异可能导致手术管理充分性的两难选择。患者与方法:2001年至2003年间,共有2910例胃腺癌患者在三星医疗中心接受了根治性手术。患者分为四组:早期胃癌(EGC)-EGC组,包括被诊断为患有胃腺癌的受试者术前和术后EGC,晚期胃癌(AGC)-EGC组,EGC-AGC组和AGC-AGC组。回顾性分析各组的临床病理特征和生存率。结果:在2,910例患者中,EGC-EGC组包括1,491例(51.2%),AGC-EGC组包括132例(4.5%),EGC-AGC组包括120例(4.1%),以及1,167例(40.1) %)在AGC-AGC组中。与EGC-EGC组相比,EGC-AGC组表现出更高的比例:上三分之一和中三分之一的肿瘤定位,2至5厘米的肿瘤大小,未分化腺癌,劳伦弥漫型,淋巴管浸润,血管浸润,和神经周围的侵犯。五年生存率取决于最终的病理阶段,而不取决于术前阶段。多因素分析显示,年龄和美国癌症联合委员会分期是患者生存的独立预后因素。结论:由于术前诊断可能不正确,因此必须在考虑肿瘤的位置,大小和细胞分化的情况下做出关于微创治疗EGC的决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号